mTOR signalling and cellular metabolism are mutual determinants in cancer

Overview of attention for article published in Nature Reviews Cancer, November 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 85 X posts from 74 X users, with an upper bound of 270,036 followers.

RT @drkohilathas: Rapamycin is now primarily used in clinical settings to suppress tissue rejection after organ transplantation and as an a…

RT @drkohilathas: Rapamycin is now primarily used in clinical settings to suppress tissue rejection after organ transplantation and as an a…

RT @drkohilathas: Rapamycin is now primarily used in clinical settings to suppress tissue rejection after organ transplantation and as an a…

RT @drkohilathas: Rapamycin is now primarily used in clinical settings to suppress tissue rejection after organ transplantation and as an a…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 81 additional X posts.